| Description | PSMA-IN-3 (compound 17) is a novel, high-affinity inhibitor of Prostate-Specific Membrane Antigen (PSMA) with an inhibitory concentration (IC50) of 13 nM, showing potential for the development of an 18F-labeled radioligand for positron emission tomography (PET) imaging of PSMA in prostate cancer [1]. |
| molecular weight | 923.89 |
| Molecular formula | C43H50FN7O15 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |